Piramal Pharma Complete Financial Statements
PPLPHARMA • Review detailed financials to uncover trends, confirm thesis & journal trades
5 Years of Data
2025 - 2021
Complete Financial Data Export
Export complete financial statements for Piramal Pharma (PPLPHARMA).
Downloads include all available records across all periods.
For market performance, see the
PPLPHARMA stock price today
.
Profitability Ratios
Net Profit Margin
-4.66%
2025 data
EBITDA Margin
11.25%
2025 data
Operating Margin
8.00%
2025 data
Return on Assets
-0.63%
2025 data
Return on Equity
-1.22%
2025 data
Balance Sheet Ratios
Current Ratio
1.53
2025 data
Debt to Equity
1.93
2025 data
Equity Ratio
51.83%
2025 data
Asset Turnover
0.14
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-8.4%
Year-over-Year
Net Profit Growth
-530.4%
Year-over-Year
EBITDA Growth
-43.1%
Year-over-Year
Expense Growth
-0.8%
Year-over-Year
Assets Growth
+2.4%
Year-over-Year
Equity Growth
+2.7%
Year-over-Year
Liabilities Growth
+2.4%
Year-over-Year
Operating Cash Flow Growth
-11.2%
Year-over-Year
Investing Cash Flow Growth
-17.3%
Year-over-Year
Financing Cash Flow Growth
-4.5%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Jun 2021 | Dec 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,124 | 2,812 | 2,031 | 2,320 | 2,591 | 1,993 | 2,233 | 1,980 | 2,196 | 1,802 | 2,034 | 1,777 | 2,229 | 1,574 | 1,814 | 1,612 | 1,345 | 1,709 |
| Expenses | 1,885 | 2,193 | 1,827 | 1,900 | 2,053 | 1,747 | 1,867 | 1,646 | 1,812 | 1,617 | 1,723 | 1,554 | 1,733 | 1,465 | 1,629 | 1,381 | 1,197 | 1,314 |
| EBITDA | 239 | 619 | 204 | 420 | 538 | 246 | 367 | 334 | 384 | 185 | 312 | 223 | 495 | 109 | 185 | 231 | 148 | 395 |
| Operating Profit Margin % | 8.00% | 20.00% | 6.00% | 15.00% | 20.00% | 10.00% | 15.00% | 14.00% | 16.00% | 8.00% | 12.00% | 10.00% | 19.00% | 1.00% | 5.00% | 12.00% | 9.00% | 15.00% |
| Depreciation | 203 | 243 | 197 | 192 | 196 | 185 | 197 | 185 | 184 | 174 | 186 | 166 | 165 | 162 | 164 | 138 | 136 | 147 |
| Interest | 82 | 104 | 86 | 108 | 114 | 107 | 103 | 110 | 104 | 119 | 106 | 83 | 57 | 62 | 95 | 49 | 42 | 50 |
| Profit Before Tax | -46 | 273 | -79 | 120 | 228 | -45 | 67 | 40 | 95 | -107 | 19 | -26 | 273 | -115 | -74 | 44 | -30 | 198 |
| Tax | 53 | 119 | 3 | 98 | 126 | 44 | 63 | 35 | 45 | -9 | 9 | 11 | 69 | -6 | 17 | 7 | -2 | 35 |
| Net Profit | -99 | 154 | -82 | 23 | 101 | -89 | 4 | 5 | 50 | -99 | 10 | -37 | 204 | -109 | -90 | 37 | -28 | 163 |
| Earnings Per Share (₹) | -0.75 | 1.16 | -0.62 | 0.17 | 0.77 | -0.67 | 0.03 | 0.04 | 0.42 | -0.83 | 0.08 | -0.31 | 1.72 | -0.92 | -0.76 | 0.31 | 0.00 | 1.38 |
Related Pages for Piramal Pharma
Additional stock information and data for PPLPHARMA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 15,678 | 15,312 | 14,523 | 12,797 | 10,900 |
| Current Assets | 5,797 | 5,465 | 4,836 | 4,067 | 3,649 |
| Fixed Assets | 8,133 | 7,990 | 7,469 | 6,879 | 6,106 |
| Capital Work in Progress | 977 | 1,116 | 1,419 | 1,172 | 627 |
| Investments | 291 | 385 | 639 | 267 | 123 |
| Other Assets | 6,277 | 5,821 | 4,996 | 4,478 | 4,045 |
| LIABILITIES | |||||
| Total Liabilities | 15,678 | 15,312 | 14,523 | 12,797 | 10,900 |
| Current Liabilities | 3,786 | 3,031 | 3,906 | 3,067 | 2,805 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 8,126 | 7,911 | 6,774 | 6,697 | 5,605 |
| Share Capital | 1,324 | 1,323 | 1,193 | 1,186 | 995 |
| Reserves & Surplus | 6,801 | 6,588 | 5,580 | 5,511 | 4,610 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | 892 | 1,005 | 484 | 766 | 598 |
| Investing Activities | -488 | -416 | -1,334 | -1,737 | -4,464 |
| Financing Activities | -441 | -422 | 818 | 794 | 3,977 |
| Net Cash Flow | -37 | 166 | -32 | -177 | 110 |